BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Okutan O, Kartaloglu Z, Ilvan A, Kutlu A, Bozkanat E, Silit E. Evaluation of high-resolution computed tomography and pulmonary function tests in patients with chronic hepatitis C virus infection. World J Gastroenterol 2004; 10(3): 381-384 [PMID: 14760762 DOI: 10.3748/wjg.v10.i3.381]
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/381.htm
Number Citing Articles
1
Richard J Wang, Mehdi Nouraie, Ken M Kunisaki, Laurence Huang, Phyllis C Tien, Kathryn Anastos, Neha Bhandari, Surya P Bhatt, Hector Bolivar, Sushma K Cribbs, Robert Foronjy, Stephen J Gange, Deepa Lazarous, Alison Morris, M Bradley Drummond. Lung Function in Women With and Without Human Immunodeficiency VirusClinical Infectious Diseases 2023; 76(3): e727 doi: 10.1093/cid/ciac391
2
Hiroshi Kanazawa. Relationship between hepatitis C virus infection and pulmonary disorders: potential mechanisms of interactionExpert Review of Clinical Immunology 2006; 2(5): 801 doi: 10.1586/1744666X.2.5.801
3
Shahira El-Etreby, Yahia Z. Gad, Amany Zeidan, Nader Elmalky, Mohamed Attiya, Adel El-Badrawy, Lamya Ibrahem. Chronic hepatitis C genotype 4 infection and interstitial pulmonary fibrosisEgyptian Liver Journal 2012; 2(3): 72 doi: 10.1097/01.ELX.0000415485.73087.c8
4
Jonathan Moorman, Mustafa Saad, Semaan Kosseifi, Guha Krishnaswamy. Hepatitis C Virus and the LungChest 2005; 128(4): 2882 doi: 10.1378/chest.128.4.2882
5
A. Pesci, P. Manganelli. Encyclopedia of Respiratory Medicine2006; : 584 doi: 10.1016/B0-12-370879-6/00103-4
6
P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois. The complex interrelationships between chronic lung and liver disease: a reviewJournal of Viral Hepatitis 2010; 17(6): 381 doi: 10.1111/j.1365-2893.2010.01307.x
7
Junia Rios Garib, Guilherme Freire Garcia, Rosângela Teixeira, Francisco das Chagas Lima e Silva. Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirinScandinavian Journal of Infectious Diseases 2011; 43(8): 625 doi: 10.3109/00365548.2011.574150
8
Giovanni Tarantino, Paolo Conca, Manuela Ariello, Maria Mastrolia, Matteo Nicola Dario Di Minno. The use of interferon-?? in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus relatedEuropean Journal of Gastroenterology & Hepatology 2005; 17(12): 1439 doi: 10.1097/00042737-200512000-00031
9
Abd El Monaem Rabea, Mohamad Zidan, Rasha Daabis, Perihan El Sayed, Sally Samir. Prevalence of chronic hepatitis C virus (HCV) infection in patients with idiopathic pulmonary fibrosisEgyptian Journal of Chest Diseases and Tuberculosis 2015; 64(4): 907 doi: 10.1016/j.ejcdt.2015.07.003
10
Patrick Marcellin, Stuart K Roberts, K Rajender Reddy, Stephen A Harrison, Donald M Jensen, Stephanos Hadziyannis, Moises Diago, Martin Weltman, Diethelm Messinger, Fernando Tatsch, Mario Rizzetto. Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studiesExpert Opinion on Drug Safety 2012; 11(6): 901 doi: 10.1517/14740338.2012.721927
11
P. Osni Leão Perin, I. de Fátma Ferreira Santana Boin, A.M. Oliveira da Silva, F. Chueiri Neto, L.C. Martins. Lung Ultrasound and Pulmonary Function Test in Cirrhotic PatientsTransplantation Proceedings 2017; 49(4): 824 doi: 10.1016/j.transproceed.2017.01.046
12
Li Yen Goh, Tim Card, Andrew W. Fogarty, Tricia M. McKeever. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: A population based study from the NHANES III databaseRespiratory Medicine 2014; 108(12): 1733 doi: 10.1016/j.rmed.2014.10.006